CVS HEALTH Corp
CVSNYSERetail-Drug Stores and Proprietary StoresFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 12/3014% above fair value
$88.51−1.74 (-1.93%)
Close on Nov 2, 2026Market cap $113.20BP/E 23.5Yield 3.01%
Cvs Health Claims Paid — Current Year Incurred by Year
Claims Paid — Current Year Incurred ($M)
Cvs Health Claims Paid — Current Year Incurred: $113,023M in FY2025, up 11.3% from a year earlier.
Latest, FY2025
113,023
Period ended Dec 31, 2025
Change on a year earlier
+11.3%
101,583 in FY2024
History
4 years
Since FY2018
Sources
1
CVS SEC 10-K (XBRL us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1)
Where the FY2025 figure comes from
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Claims Paid — Current Year Incurred ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 113,023 | +11.3% | CVS SEC 10-K (XBRL us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1) ↗ |
| FY2024 | Dec 31, 2024 | 101,583 | +34.5% | CVS SEC 10-K (XBRL us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1) ↗ |
| FY2023 | Dec 31, 2023 | 75,529 | – | CVS SEC 10-K (XBRL us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1) ↗ |
| FY2018 | Dec 31, 2018 | 6,464 | – | CVS SEC 10-K (XBRL us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1) ↗ |
Cite this data
StockData. (2026). Cvs Health Claims Paid — Current Year Incurred ($M), annual FY2018–FY2025 [Data set]. Compiled from Cvs Health SEC filings and investor materials. https://stockdatahq.com/stocks/cvs/kpis/med-paid-current-yr
See every metric in the Cvs Health KPI table. Data updated Oct 28, 2026.